Cite

HARVARD Citation

    Kobayashi, Y. et al. (n.d.). Phase I trial of volasertib, a Polo‐like kinase inhibitor, in Japanese patients with acute myeloid leukemia. Cancer science. 106 (11), pp. 1590-1595. [Online]. 
  
Back to record